What you must know about Medicamen Organics IPO?
by 5paisa Research Team
18 Jun 2024
Medicamen Organics IPO Details
- Open Date 21-Jun-24
- Close Date 25-Jun-24
- Lot Size 4000
- IPO Size ₹ 10.54 Cr
- IPO Price Range ₹ 32 to ₹ 34
- Min Investment ₹ 136,000
- Listing Exchange NSE SME
- Basis of Allotment 26-Jun-24
- Refunds 27-Jun-24
- Credit to Demat Account 27-Jun-24
- Listing Date 28-Jun-24
Medicamen Organics IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 21-Jun-24 | 1.01 | 34.20 | 78.40 | 46.90 |
| 24-Jun-24 | 1.42 | 125.47 | 345.86 | 200.58 |
| 25-Jun-24 | 173.03 | 1,342.05 | 1,290.70 | 983.62 |
Medicamen Organics IPO Synopsis
Last Updated: 25th June, 2024 by 5paisa
Medicamen Organics IPO is all set to open from 21st June to 25th June 2024. The company develops, manufactures, and distributes a wide range of pharmaceutical products. The IPO includes a fresh issue of 3,100,000 shares worth ₹10.54 cr. The share allotment date is 26th June 2024, and the IPO will be listed on 28th June 2024 on the stock exchanges. The price band is ₹32 to ₹34 and the lot size is 4000 shares.
GYR Capital Advisors Private Limited is the book-running lead manager for this IPO, while Kfin Technologies Limited is the registrar.
Objectives of Medicamen Organics IPO
Medicamen Organics Limited plans to utilize the raised capital from the IPO to:
● To fund the working capital requirement.
● To fund the working expenditure requirement for Product registration in the international markets.
● To update the plant and increase the production capacity.
● General corporate purposes.
About Medicamen Organics
Medicamen Organics develops, manufactures, and distributes a wide range of pharmaceutical products. This includes generic dosage in the form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders. The company undertakes the production for state and central government as well as for private institutions as a contract manufacturer / third-party manufacturer.
The company’s products are marketed in India as well as African, CIS and South East Asian Countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya by its third-party distributor. The company is planning to increase its global presence and has directly exported products to Burundi.
The company’s product line has 84 products which include drugs like Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Nonsteroidal anti-inflammatory drug (NSAIDS). It has 2 manufacturing units based in Haridwar, Uttarakhand which are WHO GMP-approved. It also has an ISO 9001:2015 certification.
Peer Comparison
● Brooks Laboratories Limited
● Cian Healthcare Limited
● Zenotech Laboratories Limited
For More Information:
Webstory on Medicamen Organics IPO
Medicamen Organics Financial Status
Profit and Loss
Balance Sheet
| Particulars (in Rs. Crores) | FY24 | FY23 | FY22 |
|---|---|---|---|
| Revenue from operations | 25.27 | 22.14 | 20.97 |
| EBITDA | 4.75 | 2.68 | 1.40 |
| PAT | 2.40 | 0.96 | 0.10 |
| Particulars (in Rs. Crores) | FY24 | FY23 | FY22 |
|---|---|---|---|
| Total Assets | 38.58 | 32.58 | 27.53 |
| Share Capital | 8.60 | 6.00 | 6.00 |
| Total Borrowings | 23.39 | 23.60 | 19.52 |
| Particulars (in Rs. Crores) | FY24 | FY23 | FY22 |
|---|---|---|---|
| Net cash generated from / (used in) operating activities | -3.68 | -0.58 | 0.037 |
| Net cash from / (used in) investing activities | -0.33 | -0.28 | -0.59 |
| Net cash flow from / (used in) financing activities | 4.01 | 0.93 | 0.18 |
| Net increase (decrease) in cash and cash equivalents | -0.0074 | 0.071 | -0.37 |
Medicamen Organics IPO Key Points
-
Strengths
1. The company manufactures a wide range of products.
2. Its business model is customer-centric and order-driven.
3. It focuses on high quality and is certified.
4. Experienced promoters and management team.
-
Risks
1. The company needs several approvals, licenses, registrations and permits to run the business.
2. It is subject to risks associated with expansion into new markets.
3. It is also subject to foreign currency exchange rate fluctuations.
4. It has reported negative cash flow in the past.
5. It operates in a competitive environment.
6. High working capital requirements.
Medicamen Organics
How to apply for IPO?
-
Login to your 5paisa account and select the issue in the
current IPO section -
Enter the number of lots and price at which you wish to
apply for -
Enter your UPI ID and click on submit. With this, your
bid will be placed with the exchange -
You will receive a mandate notification to block funds in
your UPI app -
Approve the mandate request on your UPI and funds
will be blocked
Open account in 5 minutes
Be a part of the 5paisa community now with 10 million mobile app users
There is some issue, try later
By Proceeding, you agree T&C*
Medicamen Organics IPO FAQs
When does Medicamen Organics IPO opens and closes?
Medicamen Organics IPO opens from 21st June to 25th June 2024.
What is the size of Medicamen Organics IPO?
The size of Medicamen Organics IPO is ₹10.54 cr.
How to apply for Medicamen Organics IPO?
To apply for Medicamen Organics IPO, follow the steps given below:
● Login to your 5paisa account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for Medicamen Organics IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
What is the price band of Medicamen Organics IPO?
The price band of Medicamen Organics IPO is fixed at ₹32 to ₹34 per share.
What is the minimum lot size and investment required for Medicamen Organics IPO?
The minimum lot size of Medicamen Organics IPO is 4000 shares and the investment required is ₹1,28,000.
What is the allotment date of Medicamen Organics IPO?
The share allotment date of Medicamen Organics IPO is 26th June 2024.
What is Medicamen Organics IPO listing date?
The Medicamen Organics IPO will be listed on 28th June 2024.
Who are the book runners for Medicamen Organics IPO?
GYR Capital Advisors Private Limited is the book-running lead manager for Medicamen Organics IPO.
What is the objective of Medicamen Organics IPO?
Medicamen Organics plans to utilize the raised capital from the IPO to:
● To fund the working capital requirement.
● To fund the working expenditure requirement for Product registration in the international markets.
● To update the plant and increase the production capacity.
● General corporate purposes.
Contact Details of Medicamen Organics IPO
Contact Information
Medicamen Organics Limited
10 Community Centre,
No 2 Ashok Vihar Phase II,
New Delhi, Delhi, 110052
Phone: +91-9818222845
Email: cs@mediorganics.in
Website: http://www.medicamenorganics.com/
Medicamen Organics IPO Register
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: medicamen.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
Medicamen Organics IPO Lead Manager
GYR Capital Advisors Private Limited
Medicamen Organics IPO Related Articles
